Clinical Study to Determine Bioequivalence of Oral Tamsulosin Products as 0.4 mg Prolonged-release Tablets in Male Subjects Under Fed Conditions

NCT07698288 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioequivalence

Interventions

DRUG: Tamsulosin 0.4 mg ER tablet
DRUG: Tamsulosin 0.4 mg ER tablet

Sponsor

ADIUM